UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000030359
Receipt No. R000034631
Scientific Title Phase II trial of eribulin in patients with recurrent glioblastoma (ENIGMA)
Date of disclosure of the study information 2017/12/19
Last modified on 2019/06/14 22:39:27

No. Disposal Last modified on Item of update
1 Insert 2017/12/12 10:21:52
2 Update 2017/12/12 10:25:16 Last name of contact person
Last name of contact person
Division name
Division name
Date of disclosure of the study information
3 Update 2017/12/12 10:59:43 Last name of contact person
Last name of contact person
Division name
Division name
4 Update 2017/12/15 10:16:17 UMIN ID1
UMIN ID2
5 Update 2017/12/15 10:19:15 Date of disclosure of the study information
6 Update 2017/12/19 19:35:12 Name of secondary funder(s)
Name of secondary funder(s)
7 Update 2017/12/19 20:39:55 Trial characteristics_1
8 Update 2018/01/20 09:59:38 Recruitment status
9 Update 2018/06/12 09:12:42 Institutions
10 Update 2019/06/14 22:39:27 UMIN ID1


Contact us.